2021

Apixaban tablet of our company has been approved for generic marketing

2021

CDE accepts our application for consistency evaluation of phenobarbital and apixaban tablets

2020

The company was renamed "Shanghai Creation Pharmaceutical Co., LTD."

2019

The company obtained the project approval of caffeine, a class II psychotropic drug

2018

Shanghai Municipal Drug Administration approved the transfer of the company's product approval documents

2017

The company has obtained the drug production license

2016

Merge Shanghai Aike Pharmaceutical and move the company to No. 428, Xihan Road, Fengxian District;The company has obtained the corresponding production qualification;

2009

The company obtained a class of psychotropic drugs Project approval of dexmethylphenidate hydrochloride

2009

The company obtained the Pharmaceutical GMP Certificate.

1981

Shanghai JinShan Phammaceutical Ltd was established